Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)
Clinical trial NCT01830959 · UNKNOWN
Trial details
- NCT number
- NCT01830959
- Sponsor
- University of Cincinnati
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.